FLNA |
FLNA, FLN, FLN1: Filamin-A |
CIB1 |
CIB1, CIB, KIP, PRKDCIP: Calcium and integrin-binding protein 1 |
0.265 |
Evidence |
|
NBN |
NBN, NBS, NBS1, P95: Nibrin |
POU2F1 |
POU2F1, OCT1, OTF1: POU domain, class 2, transcription factor 1 |
0.265 |
Evidence |
|
RBM6 |
RBM6, DEF3: RNA-binding protein 6 |
ELAVL1 |
ELAVL1, HUR: ELAV-like protein 1 |
0.265 |
Evidence |
|
PLEK |
PLEK, P47: Pleckstrin |
DYNC1LI1 |
DYNC1LI1, DNCLI1: Cytoplasmic dynein 1 light intermediate chain 1 |
0.265 |
Evidence |
|
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
0.265 |
Evidence |
|
AGT |
AGT, SERPINA8: Angiotensinogen precursor |
PCOLCE |
PCOLCE, PCPE1: Procollagen C-endopeptidase enhancer 1 precursor |
0.265 |
Evidence |
|
ROCK1 |
ROCK1: Rho-associated protein kinase 1 |
PRKD2 |
PRKD2, PKD2, HSPC187: Serine/threonine-protein kinase D2 |
0.265 |
Evidence |
|
HIVEP1 |
IPI00013444 |
TRIM28 |
TRIM28, KAP1, RNF96, TIF1B: Transcription intermediary factor 1-beta |
0.265 |
Evidence |
|
PIK3CD |
PIK3CD: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta i |
IQSEC1 |
IQSEC1, ARFGEP100, BRAG2, KIAA0763: IQ motif and Sec7 domain-containing protein |
0.265 |
Evidence |
|
DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
HSPB8 |
HSPB8, CRYAC, PP1629, E2IG1, HSP22: Heat shock protein beta-8 |
0.265 |
Evidence |
|
HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
STK38 |
STK38, NDR1: Serine/threonine-protein kinase 38 |
0.265 |
Evidence |
|
MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
APPL |
APPL1, APPL, DIP13A, KIAA1428: DCC-interacting protein 13-alpha |
0.265 |
Evidence |
|
STK16 |
IPI00480017 |
PSMA3 |
PSMA3, PSC8: Proteasome subunit alpha type-3 |
0.265 |
Evidence |
|
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
GAB2 |
IPI00186990 |
0.265 |
Evidence |
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
MAP3K5 |
MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 |
0.265 |
Evidence |
|
MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
DOCK2 |
DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 |
0.265 |
Evidence |
|
HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
0.265 |
Evidence |
|
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
FNBP1 |
IPI00102670 |
0.265 |
Evidence |
|
JUND |
JUND: Transcription factor jun-D |
IRF3 |
IRF3: Interferon regulatory factor 3 |
0.265 |
Evidence |
|
HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
RB1 |
RB1: Retinoblastoma-associated protein |
0.265 |
Evidence |
|
LIMK2 |
LIMK2: LIM domain kinase 2 |
SQSTM1 |
SQSTM1: Uncharacterized protein SQSTM1 |
0.265 |
Evidence |
|
S100A9 |
S100A9, CAGB, CFAG, MRP14: Protein S100-A9 |
TAGLN2 |
TAGLN2, RP11-48O20.1-003, hCG_39730: TAGLN2 protein |
0.265 |
Evidence |
|
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
USP34 |
USP34, KIAA0570, KIAA0729: Ubiquitin carboxyl-terminal hydrolase 34 |
0.265 |
Evidence |
|
ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
MAPKAPK2 |
MAPKAPK2: MAP kinase-activated protein kinase 2 |
0.265 |
Evidence |
|
SFRS15 |
SFRS15, KIAA1172: Splicing factor, arginine/serine-rich 15 |
RBM3 |
RBM3, RNPL: Putative RNA-binding protein 3 |
0.265 |
Evidence |
|